{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T13:47:39Z","timestamp":1774792059582,"version":"3.50.1"},"reference-count":43,"publisher":"Frontiers Media SA","funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology","doi-asserted-by":"publisher","award":["BT\/PR11782\/MED\/29\/113\/2009; Dated: 15.09.2009"],"award-info":[{"award-number":["BT\/PR11782\/MED\/29\/113\/2009; Dated: 15.09.2009"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"DOI":"10.3389\/fmicb.2016.00312","type":"journal-article","created":{"date-parts":[[2016,3,22]],"date-time":"2016-03-22T03:25:01Z","timestamp":1458617101000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["Comparative Analysis of Cellular Immune Responses in Treated Leishmania Patients and Hamsters against Recombinant Th1 Stimulatory Proteins of Leishmania donovani"],"prefix":"10.3389","volume":"7","author":[{"given":"Sumit","family":"Joshi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narendra K.","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keerti","family":"Rawat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chandra Dev P.","family":"Tripathi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anil K.","family":"Jaiswal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prashant","family":"Khare","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rati","family":"Tandon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajendra K.","family":"Baharia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanchita","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reema","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pramod K.","family":"Kushawaha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shyam","family":"Sundar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amogh A.","family":"Sahasrabuddhe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anuradha","family":"Dube","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2016,3,22]]},"reference":[{"issue":"e0116408","key":"B1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0116408","article-title":"Heterogeneity of Leishmania donovani parasites complicates diagnosis of visceral leishmaniasis: comparison of different serological tests in three endemic regions.","volume":"10","author":"Abass","year":"2015","journal-title":"PLoS ONE"},{"issue":"932549","key":"B2","doi-asserted-by":"publisher","DOI":"10.4061\/2011\/932549","article-title":"Enolase: a key player in the metabolism and a probable virulence factor of trypanosomatid parasites-perspectives for its use as a therapeutic target.","volume":"2011","author":"Avilan","year":"2011","journal-title":"Enzyme Res."},{"issue":"e0003557","key":"B3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0003557","article-title":"Recombinant NAD-dependent SIR-2 protein of Leishmania donovani: immunobiochemical characterization as a potential vaccine against visceral leishmaniasis.","volume":"9","author":"Baharia","year":"2015","journal-title":"PLoS Negl. Trop. Dis."},{"key":"B4","doi-asserted-by":"publisher","first-page":"3478","DOI":"10.1016\/j.vaccine.2012.02.075","article-title":"Ascaris suum enolase is a potential vaccine candidate against ascariasis.","volume":"30","author":"Chen","year":"2012","journal-title":"Vaccine"},{"issue":"e35","key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/cti.2015.6","article-title":"From mouse to man: safety, immunogenicity and efficacy of a candidate leishmaniasis vaccine LEISH-F3+GLA-SE.","volume":"4","author":"Coler","year":"2015","journal-title":"Clin. Transl. Immunol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"4648","DOI":"10.1128\/IAI.00394-07","article-title":"Leish-111f, a recombinant polyprotein vaccine that protects against visceral Leishmaniasis by elicitation of CD4+ T cells.","volume":"75","author":"Coler","year":"2007","journal-title":"Infect. Immun."},{"key":"B7","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1128\/CMR.19.1.111-126.2006","article-title":"Drug resistance in leishmaniasis.","volume":"19","author":"Croft","year":"2006","journal-title":"Clin. Microbiol. Rev."},{"key":"B8","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.cimid.2004.03.004","article-title":"Leishmaniasis: current situation and new perspectives.","volume":"27","author":"Desjeux","year":"2004","journal-title":"Comp. Immunol. Microbiol. Infect. Dis."},{"key":"B9","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.4049\/jimmunol.141.7.2407","article-title":"Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production.","volume":"141","author":"Ding","year":"1988","journal-title":"J. Immunol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1007\/s00436-005-1339-1","article-title":"Refractoriness to the treatment of sodium stibogluconate in Indian kala-azar field isolates persist in in vitro and in vivo experimental models.","volume":"96","author":"Dube","year":"2005","journal-title":"Parasitol. Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1093\/trstmh\/trv039","article-title":"Development of Leishmania vaccines in the era of visceral leishmaniasis elimination.","volume":"109","author":"Engwerda","year":"2015","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"issue":"e1974","key":"B12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0001974","article-title":"Leishmania donovani develops resistance to drug combinations.","volume":"6","author":"Garcia-Hernandez","year":"2012","journal-title":"PLoS Negl. Trop. Dis."},{"key":"B13","first-page":"439","article-title":"Animal models for vaccine studies for visceral leishmaniasis.","volume":"123","author":"Garg","year":"2006","journal-title":"Indian J. Med. Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"2900","DOI":"10.1016\/j.vaccine.2005.12.053","article-title":"Leishmania donovani: identification of stimulatory soluble antigenic proteins using cured human and hamster lymphocytes for their prophylactic potential against visceral leishmaniasis.","volume":"24","author":"Garg","year":"2006","journal-title":"Vaccine"},{"key":"B15","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/j.1365-2249.2005.02745.x","article-title":"Immunostimulatory cellular responses of cured Leishmania-infected patients and hamsters against the integral membrane proteins and non-membranous soluble proteins of a recent clinical isolate of Leishmania donovani.","volume":"140","author":"Garg","year":"2005","journal-title":"Clin. Exp. Immunol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1128\/CVI.05024-11","article-title":"KSAC, the first defined polyprotein vaccine candidate for visceral leishmaniasis.","volume":"18","author":"Goto","year":"2011","journal-title":"Clin. Vaccine Immunol."},{"issue":"e86073","key":"B17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0086073","article-title":"Characterization of glycolytic enzymes\u2013rAldolase and rEnolase of Leishmania donovani, identified as Th1 stimulatory proteins, for their immunogenicity and immunoprophylactic efficacies against experimental visceral leishmaniasis.","volume":"9","author":"Gupta","year":"2014","journal-title":"PLoS ONE"},{"key":"B18","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.ijpara.2012.02.013","article-title":"A novel recombinant Leishmania donovani p45, a partial coding region of methionine aminopeptidase, generates protective immunity by inducing a Th1 stimu latory response against experimental visceral leishmaniasis.","volume":"42","author":"Gupta","year":"2012","journal-title":"Int. J. Parasitol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1002\/pmic.200600725","article-title":"Proteomic approach for identification and characterization of novel immunostimulatory proteins from soluble antigens of Leishmania donovani promastigotes.","volume":"7","author":"Gupta","year":"2007","journal-title":"Proteomics"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.3201\/eid1810.111083","article-title":"Visceral leishmaniasis in rural bihar, India.","volume":"18","author":"Hasker","year":"2012","journal-title":"Emerg. Infect. Dis."},{"issue":"e108556","key":"B21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0108556","article-title":"Th1 stimulatory proteins of Leishmania donovani: comparative cellular and protective responses of rTriose phosphate isomerase, rProtein disulfide isomerase and rElongation factor-2 in combination with rHSP70 against visceral leishmaniasis.","volume":"9","author":"Jaiswal","year":"2014","journal-title":"PLoS ONE"},{"issue":"380","key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00380","article-title":"Visceral leishmaniasis: advancements in vaccine development via classical and molecular approaches.","volume":"5","author":"Joshi","year":"2014","journal-title":"Front. Immunol."},{"issue":"234fs218","key":"B23","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3009118","article-title":"Using humans to make a human leishmaniasis vaccine.","volume":"6","author":"Kamhawi","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1007\/s00436-013-3716-5","article-title":"Efficacy of Leishmania donovani trypanothione reductase, identified as a potent Th1 stimulatory protein, for its immunogenicity and prophylactic potential against experimental visceral leishmaniasis.","volume":"113","author":"Khare","year":"2014","journal-title":"Parasitol. Res."},{"key":"B25","doi-asserted-by":"publisher","first-page":"4813","DOI":"10.1016\/j.vaccine.2008.06.102","article-title":"Induction of Th1-type cellular responses in cured\/exposed Leishmania-infected patients and hamsters against polyproteins of soluble Leishmania donovani promastigotes ranging from 89.9 to 97.1 kDa.","volume":"26","author":"Kumari","year":"2008a","journal-title":"Vaccine"},{"key":"B26","doi-asserted-by":"publisher","first-page":"5700","DOI":"10.1016\/j.vaccine.2008.08.021","article-title":"Th1-stimulatory polyproteins of soluble Leishmania donovani promastigotes ranging from 89.9 to 97.1 kDa offers long-lasting protection against experimental visceral leishmaniasis.","volume":"26","author":"Kumari","year":"2008b","journal-title":"Vaccine"},{"key":"B27","doi-asserted-by":"publisher","first-page":"6417","DOI":"10.4049\/jimmunol.1102081","article-title":"Elongation factor-2, a Th1 stimulatory protein of Leishmania donovani, generates strong IFN-gamma and IL-12 response in cured Leishmania-infected patients\/hamsters and protects hamsters against Leishmania challenge.","volume":"187","author":"Kushawaha","year":"2011","journal-title":"J. Immunol."},{"issue":"e45766","key":"B28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0045766","article-title":"Leishmania donovani triose phosphate isomerase: a potential vaccine target against visceral leishmaniasis.","volume":"7","author":"Kushawaha","year":"2012a","journal-title":"PLoS ONE"},{"issue":"e35670","key":"B29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0035670","article-title":"Evaluation of Leishmania donovani protein disulfide isomerase as a potential immunogenic protein\/vaccine candidate against visceral Leishmaniasis.","volume":"7","author":"Kushawaha","year":"2012b","journal-title":"PLoS ONE"},{"key":"B30","doi-asserted-by":"publisher","first-page":"5526","DOI":"10.1016\/j.vaccine.2011.05.030","article-title":"Immunisation with the glycolytic enzyme enolase confers effective protection against Candida albicans infection in mice.","volume":"29","author":"Li","year":"2011","journal-title":"Vaccine"},{"key":"B31","doi-asserted-by":"publisher","first-page":"34111","DOI":"10.1074\/jbc.M113.515544","article-title":"Elongation factor-1alpha is a novel protein associated with host cell invasion and a potential protective antigen of Cryptosporidium parvum.","volume":"288","author":"Matsubayashi","year":"2013","journal-title":"J. Biol. Chem."},{"key":"B32","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1111\/imm.12104","article-title":"Heat-shock proteins as dendritic cell-targeting vaccines\u2013getting warmer.","volume":"139","author":"McNulty","year":"2013","journal-title":"Immunology"},{"key":"B33","doi-asserted-by":"publisher","first-page":"4","DOI":"10.4103\/2229-5070.129142","article-title":"Drug resistance in leishmaniasis: newer developments.","volume":"4","author":"Mohapatra","year":"2014","journal-title":"Trop. Parasitol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0165-2427(02)00315-X","article-title":"A Leishmania infantum multi-component antigenic protein mixed with live BCG confers protection to dogs experimentally infected with L. infantum.","volume":"92","author":"Molano","year":"2003","journal-title":"Vet. Immunol. Immunopathol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"5500","DOI":"10.1128\/IAI.00551-07","article-title":"Protective properties and surface localization of Plasmodium falciparum enolase.","volume":"75","author":"Pal-Bhowmick","year":"2007","journal-title":"Infect. Immun."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1086\/375356","article-title":"Identification of immunoreactive proteins during acute human giardiasis.","volume":"187","author":"Palm","year":"2003","journal-title":"J. Infect. Dis."},{"key":"B37","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/j.0141-9838.2004.00711.x","article-title":"Adjuvant guided polarization of the immune humoral response against a protective multicomponent antigenic protein (Q) from Leishmania infantum. A CpG + Q mix protects Balb\/c mice from infection.","volume":"26","author":"Parody","year":"2004","journal-title":"Parasite Immunol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"3088","DOI":"10.1128\/JCM.00173-11","article-title":"Unusual case of resistance to amphotericin B in visceral leishmaniasis in a region in India where leishmaniasis is not endemic.","volume":"49","author":"Srivastava","year":"2011","journal-title":"J. Clin. Microbiol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/sj.icb7100011","article-title":"Balancing immunity and pathology in visceral leishmaniasis.","volume":"85","author":"Stanley","year":"2007","journal-title":"Immunol. Cell Biol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"3333","DOI":"10.1016\/j.vaccine.2010.02.089","article-title":"Treatment of canine visceral leishmaniasis by the vaccine Leish-111f+MPL-SE.","volume":"28","author":"Trigo","year":"2010","journal-title":"Vaccine"},{"key":"B41","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1111\/j.1365-2249.2005.03000.x","article-title":"Identification of Leishmania donovani antigens stimulating cellular immune responses in exposed immune individuals.","volume":"143","author":"Tripathi","year":"2006","journal-title":"Clin. Exp. Immunol."},{"issue":"e70884","key":"B42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0070884","article-title":"Toxoplasma gondii protein disulfide isomerase (TgPDI) is a novel vaccine candidate against toxoplasmosis.","volume":"8","author":"Wang","year":"2013","journal-title":"PLoS ONE"},{"key":"B43","doi-asserted-by":"publisher","first-page":"3422","DOI":"10.1016\/j.febslet.2013.09.022","article-title":"Triose phosphate isomerase from the blood fluke Schistosoma mansoni: biochemical characterisation of a potential drug and vaccine target.","volume":"587","author":"Zinsser","year":"2013","journal-title":"FEBS Lett."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T09:06:24Z","timestamp":1692263184000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/Article\/10.3389\/fmicb.2016.00312\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,22]]},"references-count":43,"URL":"https:\/\/doi.org\/10.3389\/fmicb.2016.00312","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,22]]}}}